Tag: equity
-
Infographic – Google’s Largest Acquisitions
Our friends at Statista yesterday published this chart showing Google/Alphabet’s largest acquisitions over the years.
-
Neuro Disease Start-Up Gains $30M in Early Funds
A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round.
-
3-D Organ Printing Company Gains Seed Funds
A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital.
-
Synthetic DNA Start-Up Raises $13M in Early Funds
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round.
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.
-
Engineered T-Cell Company Acquired for $11.9 Billion
A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion.
-
University Spins Off Educational Robot Start-Up
A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.
-
S&P 500 Tech Stocks Surpass Dot-Com Peak
On Wednesday, Standard & Poor’s index of 500 stocks in the information technology industry closed at 992.29, its highest point since March 2000, at the height of the dot-com boom, when the index reached 988.49.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.